What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019

According to key diabetic studies, the early use of metformin glucose lowering therapy is associated with a reduced risk of developing micro- and, in the long term, 10-year follow-up, macrovascular complications and cardiovascular mortality. Short-term studies results on combined glucose lowering th...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina V. Shestakova, Mikhail B. Antsiferov, Alexander S. Ametov, Gagik R. Galstyan, Tatiana Y. Demidova, Alexey V. Zilov, Tatiana N. Markova, Nina A. Petunina, Natalya A. Chernikova, Minara S. Shamkhalova
Format: Article
Language:English
Published: Endocrinology Research Centre 2020-04-01
Series:Сахарный диабет
Subjects:
diabetes mellitus
vildagliptin
metformin
hba1c
new onset diabetes mellitus
Online Access:https://www.dia-endojournals.ru/jour/article/view/12404
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dia-endojournals.ru/jour/article/view/12404

Similar Items